Agency Forms Undergoing Paperwork Reduction Act Review, 65394-65396 [2019-25746]
Download as PDF
<![CDATA[
65394
Federal Register / Vol. 84, No. 229 / Wednesday, November 27, 2019 / Notices
proposed collection of information,
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570 or
send an email to omb@cdc.gov. Direct
written comments and/or suggestions
regarding the items contained in this
notice to the Attention: CDC Desk
Officer, Office of Management and
Budget, 725 17th Street NW,
Washington, DC 20503 or by fax to (202)
395–5806. Provide written comments
within 30 days of notice publication.
Proposed Project
National Electronic Health Records
Survey (NEHRS) (OMB Control No.
0920–1015, Exp. 07/31/2020)—
Revision—National Center for Health
Statistics (NCHS), Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
The National Electronic Health
Records Survey (NEHRS) is a national
survey of office-based physicians
conducted by the National Center for
Health Statistics (NCHS), Centers for
Disease Control and Prevention (CDC).
NEHRS is sponsored by the Office of the
National Coordinator for Health
Information Technology (ONC),
Department of Health and Human
Services (DHHS). The survey is
conducted under the authority of
Section 306 of the Public Health Service
Act (41 U.S.C. 242k).
The purpose of this study is to collect
information on office-based physicians’
adoption and use of electronic health
record (EHR) systems, practice
information, patient engagement,
controlled substances prescribing
practices, use of health information
exchange, and documentation and
burden associated with medical record
systems. The respondents are a sample
of office-based physicians. Data
collection is done directly through a
self-administered web questionnaire,
self-administered paper questionnaire or
computer-assisted telephone interview.
NEHRS collects information on
characteristics of U.S. office-based
physicians practicing ambulatory
medical care, including specific focus
on EHR adoption and use.
Having data that can identify a
physician office’s ability to perform
specific computerized tasks helps track
the adoption and use of new health
information technologies across various
physician and practice characteristics
(e.g., specialty, office type, and
ownership) over time. These annual
data, together with trend data, may be
used to monitor the effects of change in
the health care system, provide new
insights into ambulatory medical care,
and stimulate further research on the
use, organization, and delivery of
ambulatory care.
Data from the National Electronic
Health Records Survey (NEHRS) have
been used by researchers in reports and
programs such as Health, United States
and Healthy People 2020, in addition to
various other reports and research
across federal, public, and international
communities. The results of the data
will help provide more information
about the use and adoption of EHRs by
office-based physicians both nationally
and by state.
A total of 5,151 annualized burden
hours are requested for this three-year
submission.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Type of respondents
Form name
Office-based Physicians or office staff ...........
NEHRS ...........................................................
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2019–25749 Filed 11–26–19; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–20–1178]
Agency Forms Undergoing Paperwork
Reduction Act Review
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled Comprehensive
HIV Prevention and Care for Men Who
VerDate Sep<11>2014
20:21 Nov 26, 2019
Jkt 250001
Have Sex with Men of Color to the
Office of Management and Budget
(OMB) for review and approval. CDC
previously published a ‘‘Proposed Data
Collection Submitted for Public
Comment and Recommendations’’
notice on August 13, 2019 to obtain
comments from the public and affected
agencies. CDC did not receive comments
related to the previous notice. This
notice serves to allow an additional 30
days for public and affected agency
comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
PO 00000
Frm 00048
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
10,302
1
Average
burden per
response
(in hours)
30/60
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
E:\FR\FM\27NON1.SGM
27NON1
Federal Register / Vol. 84, No. 229 / Wednesday, November 27, 2019 / Notices
instruments, call (404) 639–7570 or
send an email to omb@cdc.gov. Direct
written comments and/or suggestions
regarding the items contained in this
notice to the Attention: CDC Desk
Officer, Office of Management and
Budget, 725 17th Street NW,
Washington, DC 20503 or by fax to (202)
395–5806. Provide written comments
within 30 days of notice publication.
Proposed Project
Comprehensive HIV Prevention and
Care for Men Who Have Sex with Men
of Color (OMB Contrtol No. 0920–1178,
Exp. 4/30/2020)—Extension—National
Center for HIV/AIDS, Viral Hepatitis,
STD, and TB Prevention (NCHHSTP),
Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
Approximately 40,000 people in the
United States are newly infected with
HIV each year. Gay, bisexual, and other
men who have sex with men (MSM)
remain the population most affected by
HIV infection in the United States (US).
Among MSM, those who are black and
Hispanic comprise 64% of all new
infections. Goals of the National HIV
Prevention Strategy and the new
initiative ‘‘Ending the HIV Epidemic: A
Plan for America’’ include increasing
the number of MSM of color living with
HIV infection who achieve HIV viral
suppression with antiretroviral
treatment (ART), and decreasing the
number of new HIV infections among
MSM of color at risk of acquiring an HIV
infection.
Antiretroviral (ARV) medications for
pre-exposure prophylaxis (PrEP) can be
used for HIV prevention by MSM at
substantial risk for HIV acquisition or by
those with a possible HIV exposure in
the past 72 hours post-exposure
prophylaxis (nPEP). The daily use of coformulated tenofovir disoproxil
fumarate and emtricitabine (marketed as
Truvada) for PrEP has been proven to
significantly reduce the risk of HIV
acquisition among sexually active MSM.
In July 2012, the US Food and Drug
Administration (FDA) approved an HIV
prevention indication for Truvada, and
in May 2014 CDC published clinical
practice guidelines for provision of
PrEP. Given the high incidence of HIV
among MSM of color, those who are
sexually active are considered at risk for
HIV acquisition and thus could benefit
from prevention services such as routine
and frequent HIV screening with labbased fourth generation HIV tests,
routine screening for STDs, assessment
of PrEP eligibility, provision of PrEP (if
at substantial risk for HIV acquisition),
provision of nPEP (if a possible HIV
VerDate Sep<11>2014
20:21 Nov 26, 2019
Jkt 250001
exposure occurred in the past 72 hours),
and/or other risk reduction
interventions.
Among people living with HIV
(PLWH), ARV treatment can suppress
HIV viral load, which both improves
health outcomes of individuals and
reduces the risk of HIV transmission.
Two studies, one that demonstrated the
effectiveness of ARV treatment in
preventing HIV transmission, and one
that demonstrated improved health
outcomes for individuals whose ARV
treatment was initiated immediately,
have led to increased public health
focus on interventions and strategies
designed to initiate ARV treatment, link,
retain, and re-engage PLWH in HIV care,
and to provide support for adherence to
ARV medications.
The purpose of this project is to
support state and local health
departments to develop and implement
demonstration projects for provision of
comprehensive HIV prevention and care
services for MSM of color by creating a
collaborative with CBOs, clinics and
other health care providers, and
behavioral health and social services
providers in their jurisdiction.
Behavioral health services include
mental health and substance abuse
treatment to enable MSM of color to
utilize HIV prevention and care
services; social services include services
that promote access to housing, job
counseling, and employment services to
enable MSM of color to utilize HIV
prevention and care services.
Comprehensive models of HIV
prevention and care for MSM of color
will be developed and implemented by
a collaborative that is led by the
jurisdiction’s health department and
includes the following: Health care
providers (e.g., federally qualified
health centers (FQHCs), FQHC LookAlikes, other clinics, or health care
providers); HIV care providers (e.g.,
clinics funded through the Ryan White
HIV/AIDS Program (RWHAP clinics),
other HIV care clinics, or HIV care
providers); behavioral health and social
services providers (i.e., mental health
and substance abuse services, housing
programs, and job training or
employment services); and community
based organizations (CBOs). Principles
of high impact prevention should guide
the selection and implementation of
activities and strategies to focus on
MSM of color at substantial risk for HIV
infection (i.e., eligible for prevention
with PrEP), and those living with HIV.
MSM of color who are at risk for HIV
acquisition but not eligible for or
decline PrEP will be provided risk
reduction interventions, partner services
PO 00000
Frm 00049
Fmt 4703
Sfmt 4703
65395
if diagnosed with an STD, re-testing for
HIV and STDs in 3–6 months, and
behavioral health and social services.
The risk of HIV acquisition should be
assessed at every encounter with an
individual, and MSM of color at
substantial risk of HIV acquisition
should be offered PrEP when indicated
by the risk assessment.
There are a total of 24 required HIV
prevention and care services that must
be provided by the health department
collaborative for this project, including
13 HIV prevention services for MSM of
color at substantial risk for HIV
infection and 11 HIV care services for
MSM of color living with HIV infection.
HIV prevention services include: (1)
HIV testing that uses lab-based 4th
generation HIV tests; (2) Assessment of
indications for pre-exposure
prophylaxis (PrEP) and nonoccupational post- exposure
prophylaxis (nPEP); (3) Provision of
PrEP and nPEP; (4) Adherence
interventions for PrEP and nPEP; (5)
Immediate linkage to care, ARV
treatment, and partner services for those
diagnosed with acute HIV infection; (6)
Expedient linkage to care, ARV
treatment, and partner services for those
diagnosed with established HIV
infection; (7) STD screening and
treatment; (8) Partner services for
patients with STDs; (9) Behavioral risk
reduction interventions; (10) Screening
for behavioral health and social services
needs; (11) Linkage to behavioral health
and social services; (12) Navigators to
assist utilizing HIV prevention and
behavioral health and social services;
and (13) Navigators to assist enrollment
in a health plan.
HIV care services include: (1) HIV
primary care, including antiretroviral
(ARV) treatment; (2) Retention
interventions; (3) Re-engagement
interventions; (4) Adherence
interventions; (5) STD screening and
treatment; (6) Partner services; (7)
Behavioral risk reduction interventions;
(8) Screening patients for behavioral
health and social services needs; (9)
Linkage to behavioral health and social
services; (10) Navigators to assist linking
to care and accessing behavioral health
and social services; and (11) Navigators
to assist enrollment in a health plan.
CDC HIV program grantees will
collect, enter or upload, and report
agency-identifying information, budget
data, information on HIV prevention
and care services, and client
demographic characteristics. The total
annual burden hours are 1,534 hours.
There are no other costs to respondents
other than their time.
E:\FR\FM\27NON1.SGM
27NON1
65396
Federal Register / Vol. 84, No. 229 / Wednesday, November 27, 2019 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS
Form name
THRIVE Partners ............................................
Monitoring and Evaluation Data Elements on
HIV Prevention and Care Services.
Qualitative Interview: Collaborative Process
Evaluation.
Collaborative Assessment Tool .....................
Monitoring and Evaluation Data Elements on
HIV Prevention and Care Services.
Qualitative Interview: Collaborative Process
Evaluation.
Collaborative Assessment Tool .....................
Funding Allocation Report ..............................
THRIVE Awardees ..........................................
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2019–25746 Filed 11–26–19; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifier CMS–10630 and CMS–
855S]
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Centers for Medicare &
Medicaid Services, HHS.
ACTION: Notice.
AGENCY:
The Centers for Medicare &
Medicaid Services (CMS) is announcing
an opportunity for the public to
comment on CMS’ intention to collect
information from the public. Under the
Paperwork Reduction Act of 1995
(PRA), federal agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information, including each proposed
extension or reinstatement of an existing
collection of information, and to allow
a second opportunity for public
comment on the notice. Interested
persons are invited to send comments
regarding the burden estimate or any
other aspect of this collection of
information, including the necessity and
utility of the proposed information
collection for the proper performance of
the agency’s functions, the accuracy of
the estimated burden, ways to enhance
the quality, utility, and clarity of the
information to be collected, and the use
of automated collection techniques or
other forms of information technology to
SUMMARY:
VerDate Sep<11>2014
20:21 Nov 26, 2019
Jkt 250001
Number of
responses per
respondent
Number of
respondents
Type of respondent
Average
burden per
response
(in hours)
80
2
9
80
1
40/60
80
7
1
2
20/60
1
7
1
40/60
7
7
1
1
20/60
20/60
minimize the information collection
burden.
3506(c)(2)(A) of the PRA (44 U.S.C.
3506(c)(2)(A)) requires federal agencies
to publish a 30-day notice in the
DATES: Comments on the collection(s) of
Federal Register concerning each
information must be received by the
OMB desk officer by December 27, 2019. proposed collection of information,
including each proposed extension or
ADDRESSES: When commenting on the
reinstatement of an existing collection
proposed information collections,
of information, before submitting the
please reference the document identifier collection to OMB for approval. To
or OMB control number. To be assured
comply with this requirement, CMS is
consideration, comments and
publishing this notice that summarizes
recommendations must be received by
the following proposed collection(s) of
the OMB desk officer via one of the
information for public comment:
following transmissions:
1. Type of Information Collection
OMB, Office of Information and
Request: Revision with change of a
Regulatory Affairs, Attention: CMS Desk currently approved collection; Title of
Officer, Fax Number: (202) 395–5806
Information Collection: Programs of AllOR, Email: OIRA_submission@
Inclusive Care for the Elderly (PACE)
omb.eop.gov.
2020 Audit Protocol; Use: Sections
To obtain copies of a supporting
1894(e)(4) and 1934(e)(4) of the Act and
statement and any related forms for the
the implementing regulations at 42 CFR
proposed collection(s) summarized in
460.190 and 460.192 mandate that CMS,
this notice, you may make your request
in conjunction with the SAA, audit
using one of following:
PACE organizations (POs) annually for
1. Access CMS’ website address at
the first 3 years (during the trial period),
website address at https://www.cms.gov/ and then at least every 2 years following
Regulations-and-Guidance/Legislation/
the trial period. The information
PaperworkReductionActof1995/PRAgathered during this audit will be used
Listing.html.
by the Medicare Parts C and D Oversight
1. Email your request, including your
and Enforcement Group (MOEG) within
address, phone number, OMB number,
the Center for Medicare (CM) and CMS
and CMS document identifier, to
Regional Offices, as well as the SAA, to
Paperwork@cms.hhs.gov.
assess PO’s compliance with PACE
2. Call the Reports Clearance Office at program requirements. If outliers or
(410) 786–1326.
other data anomalies are detected, CMS’
FOR FURTHER INFORMATION CONTACT:
Regional Offices will work in
William Parham at (410) 786–4669.
collaboration with MOEG and other
SUPPLEMENTARY INFORMATION: Under the
divisions within CMS for follow-up and
Paperwork Reduction Act of 1995 (PRA) resolution. Additionally, POs will
(44 U.S.C. 3501–3520), federal agencies
receive the audit results, and will be
must obtain approval from the Office of
required to implement corrective action
Management and Budget (OMB) for each to correct any identified deficiencies.
CMS currently uses 18 data collection
collection of information they conduct
instruments for conducting PACE
or sponsor. The term ‘‘collection of
audits. These instruments are
information’’ is defined in 44 U.S.C.
categorized as a PACE audit process and
3502(3) and 5 CFR 1320.3(c) and
data request, a questionnaire, a preincludes agency requests or
requirements that members of the public audit issue summary, a Root Cause
submit reports, keep records, or provide Analysis template and 16 impact
analyses templates. Beginning in audit
information to a third party. Section
PO 00000
Frm 00050
Fmt 4703
Sfmt 4703
E:\FR\FM\27NON1.SGM
27NON1
]]>Agencies
[Federal Register Volume 84, Number 229 (Wednesday, November 27, 2019)]
[Notices]
[Pages 65394-65396]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-25746]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-20-1178]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled Comprehensive HIV Prevention and Care for Men
Who Have Sex with Men of Color to the Office of Management and Budget
(OMB) for review and approval. CDC previously published a ``Proposed
Data Collection Submitted for Public Comment and Recommendations''
notice on August 13, 2019 to obtain comments from the public and
affected agencies. CDC did not receive comments related to the previous
notice. This notice serves to allow an additional 30 days for public
and affected agency comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and
[[Page 65395]]
instruments, call (404) 639-7570 or send an email to [email protected].
Direct written comments and/or suggestions regarding the items
contained in this notice to the Attention: CDC Desk Officer, Office of
Management and Budget, 725 17th Street NW, Washington, DC 20503 or by
fax to (202) 395-5806. Provide written comments within 30 days of
notice publication.
Proposed Project
Comprehensive HIV Prevention and Care for Men Who Have Sex with Men
of Color (OMB Contrtol No. 0920-1178, Exp. 4/30/2020)--Extension--
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
(NCHHSTP), Centers for Disease Control and Prevention (CDC).
Background and Brief Description
Approximately 40,000 people in the United States are newly infected
with HIV each year. Gay, bisexual, and other men who have sex with men
(MSM) remain the population most affected by HIV infection in the
United States (US). Among MSM, those who are black and Hispanic
comprise 64% of all new infections. Goals of the National HIV
Prevention Strategy and the new initiative ``Ending the HIV Epidemic: A
Plan for America'' include increasing the number of MSM of color living
with HIV infection who achieve HIV viral suppression with
antiretroviral treatment (ART), and decreasing the number of new HIV
infections among MSM of color at risk of acquiring an HIV infection.
Antiretroviral (ARV) medications for pre-exposure prophylaxis
(PrEP) can be used for HIV prevention by MSM at substantial risk for
HIV acquisition or by those with a possible HIV exposure in the past 72
hours post-exposure prophylaxis (nPEP). The daily use of co-formulated
tenofovir disoproxil fumarate and emtricitabine (marketed as Truvada)
for PrEP has been proven to significantly reduce the risk of HIV
acquisition among sexually active MSM. In July 2012, the US Food and
Drug Administration (FDA) approved an HIV prevention indication for
Truvada, and in May 2014 CDC published clinical practice guidelines for
provision of PrEP. Given the high incidence of HIV among MSM of color,
those who are sexually active are considered at risk for HIV
acquisition and thus could benefit from prevention services such as
routine and frequent HIV screening with lab-based fourth generation HIV
tests, routine screening for STDs, assessment of PrEP eligibility,
provision of PrEP (if at substantial risk for HIV acquisition),
provision of nPEP (if a possible HIV exposure occurred in the past 72
hours), and/or other risk reduction interventions.
Among people living with HIV (PLWH), ARV treatment can suppress HIV
viral load, which both improves health outcomes of individuals and
reduces the risk of HIV transmission. Two studies, one that
demonstrated the effectiveness of ARV treatment in preventing HIV
transmission, and one that demonstrated improved health outcomes for
individuals whose ARV treatment was initiated immediately, have led to
increased public health focus on interventions and strategies designed
to initiate ARV treatment, link, retain, and re-engage PLWH in HIV
care, and to provide support for adherence to ARV medications.
The purpose of this project is to support state and local health
departments to develop and implement demonstration projects for
provision of comprehensive HIV prevention and care services for MSM of
color by creating a collaborative with CBOs, clinics and other health
care providers, and behavioral health and social services providers in
their jurisdiction. Behavioral health services include mental health
and substance abuse treatment to enable MSM of color to utilize HIV
prevention and care services; social services include services that
promote access to housing, job counseling, and employment services to
enable MSM of color to utilize HIV prevention and care services.
Comprehensive models of HIV prevention and care for MSM of color
will be developed and implemented by a collaborative that is led by the
jurisdiction's health department and includes the following: Health
care providers (e.g., federally qualified health centers (FQHCs), FQHC
Look-Alikes, other clinics, or health care providers); HIV care
providers (e.g., clinics funded through the Ryan White HIV/AIDS Program
(RWHAP clinics), other HIV care clinics, or HIV care providers);
behavioral health and social services providers (i.e., mental health
and substance abuse services, housing programs, and job training or
employment services); and community based organizations (CBOs).
Principles of high impact prevention should guide the selection and
implementation of activities and strategies to focus on MSM of color at
substantial risk for HIV infection (i.e., eligible for prevention with
PrEP), and those living with HIV. MSM of color who are at risk for HIV
acquisition but not eligible for or decline PrEP will be provided risk
reduction interventions, partner services if diagnosed with an STD, re-
testing for HIV and STDs in 3-6 months, and behavioral health and
social services. The risk of HIV acquisition should be assessed at
every encounter with an individual, and MSM of color at substantial
risk of HIV acquisition should be offered PrEP when indicated by the
risk assessment.
There are a total of 24 required HIV prevention and care services
that must be provided by the health department collaborative for this
project, including 13 HIV prevention services for MSM of color at
substantial risk for HIV infection and 11 HIV care services for MSM of
color living with HIV infection.
HIV prevention services include: (1) HIV testing that uses lab-
based 4th generation HIV tests; (2) Assessment of indications for pre-
exposure prophylaxis (PrEP) and non-occupational post- exposure
prophylaxis (nPEP); (3) Provision of PrEP and nPEP; (4) Adherence
interventions for PrEP and nPEP; (5) Immediate linkage to care, ARV
treatment, and partner services for those diagnosed with acute HIV
infection; (6) Expedient linkage to care, ARV treatment, and partner
services for those diagnosed with established HIV infection; (7) STD
screening and treatment; (8) Partner services for patients with STDs;
(9) Behavioral risk reduction interventions; (10) Screening for
behavioral health and social services needs; (11) Linkage to behavioral
health and social services; (12) Navigators to assist utilizing HIV
prevention and behavioral health and social services; and (13)
Navigators to assist enrollment in a health plan.
HIV care services include: (1) HIV primary care, including
antiretroviral (ARV) treatment; (2) Retention interventions; (3) Re-
engagement interventions; (4) Adherence interventions; (5) STD
screening and treatment; (6) Partner services; (7) Behavioral risk
reduction interventions; (8) Screening patients for behavioral health
and social services needs; (9) Linkage to behavioral health and social
services; (10) Navigators to assist linking to care and accessing
behavioral health and social services; and (11) Navigators to assist
enrollment in a health plan.
CDC HIV program grantees will collect, enter or upload, and report
agency-identifying information, budget data, information on HIV
prevention and care services, and client demographic characteristics.
The total annual burden hours are 1,534 hours. There are no other costs
to respondents other than their time.
[[Page 65396]]
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per
Type of respondent Form name respondents responses per response (in
respondent hours)
----------------------------------------------------------------------------------------------------------------
THRIVE Partners....................... Monitoring and 80 2 9
Evaluation Data
Elements on HIV
Prevention and Care
Services.
Qualitative Interview: 80 1 40/60
Collaborative Process
Evaluation.
Collaborative Assessment 80 1 20/60
Tool.
THRIVE Awardees....................... Monitoring and 7 2 1
Evaluation Data
Elements on HIV
Prevention and Care
Services.
Qualitative Interview: 7 1 40/60
Collaborative Process
Evaluation.
Collaborative Assessment 7 1 20/60
Tool.
Funding Allocation 7 1 20/60
Report.
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2019-25746 Filed 11-26-19; 8:45 am]
BILLING CODE 4163-18-P
